Latest news with #T.RowePriceHealthCareETF
Business Insider
2 days ago
- Business
- Business Insider
UnitedHealth Stock (UNH) Tumbles 50% YTD; Here's How to Buy the Dip Without the Risk
UnitedHealth Group (UNH), the largest U.S. health insurer, recently suffered one of its worst stock plunges, down over 50% year-to-date following weak Q1 earnings and a lower full-year outlook. For long-term investors, this dramatic dip may present a buying opportunity, especially through exchange-traded funds (ETFs) that offer diversified exposure to UNH without the risk of holding the stock directly. Thus, investors seeking exposure to UNH stock may consider the Harbor Health Care ETF (MEDI) and T. Rowe Price Health Care ETF (TMED). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Let's take a deeper look at these two ETFs. Harbor Health Care ETF The MEDI ETF is an actively managed fund that targets long-term capital growth by investing in healthcare companies. The ETF provides exposure to UnitedHealth stock alongside other major players like Ascendis Pharma (ASND), Eli Lilly (LLY), and Legend Biotech (LEGN). Importantly, UNH accounts for 5.6% of the MEDI ETF's total holdings. Overall, the ETF has $16.24 million in assets under management (AUM). Also, it has an expense ratio of 0.8%. Over the past three months, the MEDI ETF has generated a return of 5%. On TipRanks, MEDI has a Strong Buy consensus rating based on 36 Buys and two Holds assigned in the last three months. At $37.67, the average MEDI ETF price target implies 42.79% upside potential. T. Rowe Price Health Care ETF The TMED ETF is an actively managed fund that aims to capture long-term growth opportunities in the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. UNH stock constitutes 5.91% of the ETF's holdings. Apart from UnitedHealth, some of the top stocks in the TMED ETF are AbbVie (ABBV), Abbott (ABT), and Danaher (DHR). Overall, the ETF has $11.81 million in AUM. Also, it has an expense ratio of 0.44%. The TMED ETF has declined 5.35% in the past three months. Turning to Wall Street, the ETF has a Moderate Buy consensus rating. Of the 110 stocks held, 99 have Buys, 10 have Holds, and one Sell rating. At $33.65, the average TMED ETF price target implies a 41.31% upside potential. Concluding Thoughts ETFs provide indirect exposure to UNH stock, reducing risk compared to investing directly in the stock. Furthermore, ETFs are a liquid and transparent way to participate in the market. Investors seeking ETF recommendations might consider MEDI and TMED, as these ETFs offer exposure to UnitedHealth stock.
Yahoo
12-06-2025
- Business
- Yahoo
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22 BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings. Each of the three funds represents new and distinct strategies and has an expense ratio of 0.44%. The ETFs seek to provide long-term capital appreciation growth through exposure to their respective sectors: T. Rowe Price Financials ETF (TFNS) invests at least 80 percent of its net assets in securities of companies servicing and operating in the financial services industry and typically maintains a portfolio of 50-70 companies. TFNS is managed by Matt Snowling, CFA® and Greg Locraft, two portfolio managers of the T. Rowe Price Financial Services Equity strategy. T. Rowe Price Health Care ETF (TMED) invests at least 80 percent of its net assets in the securities of health care companies engaged in health care innovations. The fund's portfolio typically consists of 100 to 150 stocks and is diversified across health care, with a focus on biotechnology, pharmaceuticals, products and device providers, and health care service companies. TMED will be co-managed by Sal Rais, who covers biotech companies, and Jon Wood, who covers life science and diagnostic tools, and medical supplies and devices. T. Rowe Price Natural Resources ETF (TURF) invests at least 80 percent of its net assets in the securities of natural resource companies, with primary focus on those engaged in the upstream extraction of energy, minerals and agriculture products. The fund typically holds 60-80 securities and invests in resource companies on a global basis. TURF is co-managed by five investment professionals: Rick de los Reyes, head of Commodities; and portfolio manager, Global Natural Resources Equity strategy Shinwoo Kim, portfolio manager, Global Natural Resources Equity strategy Priyal Maniar, CFA®, co-portfolio manager, TURF ETF; and investment analyst, North America Energy John Qian, portfolio manager, Metals and Mining strategy Tom Shelmerdine, portfolio manager, Precious Metals strategy T. Rowe Price introduced its first active ETFs in 2020, and today's launches bring the firm's lineup to 16 equity active ETFs and six fixed income active ETFs. The funds deliver key features associated with ETFs such as tax efficiency, more competitive expense ratios, and the flexibility to buy and sell shares throughout the trading day. Designed to outperform passive indexes, each T. Rowe Price active ETF applies the longstanding investing capabilities of the firm's active managers, based on rigorous global research and the regular practice of asking better questions, as they strive to deliver better investment outcomes for clients. QUOTE:Tim Coyne, Global Head of Exchange-Traded Funds"The launches of TMED, TURF, and TFNS reflect our ongoing commitment to deliver an array of active ETFs that meet the evolving needs of our clients. We remain focused on growing our active ETF business and look forward to continuing to build it with compelling investing ideas and the best thinking of T. Rowe Price active managers." ABOUT T. ROWE PRICE Founded in 1937, T. Rowe Price (NASDAQ: TROW) helps people around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Investors rely on the award-winning firm for its retirement expertise and active management approach of equity, fixed income, alternatives, and multi-asset investment capabilities. T. Rowe Price manages USD $1.62 trillion in assets under management as of May 31, 2025, and serves millions of clients globally. News and other updates can be found on Facebook, Instagram, LinkedIn, Twitter, YouTube, and Consider the investment objectives, risks, and charges and expenses carefully before investing. For a prospectus or, if available, a summary prospectus containing this and other information visit Read it carefully. ETFs are bought and sold at market prices, not net asset value (NAV). Investors generally incur the cost of the spread between the prices at which shares are bought and sold. Buying and selling shares may result in brokerage commissions which will reduce returns. View original content to download multimedia: SOURCE T. Rowe Price Group Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
